About the Authors

Elizabeth Stucky Hunter

Roles Formal analysis, Investigation, Methodology, Visualization, Writing – original draft

Affiliation Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom

Iain D. Page

Roles Data curation, Resources, Writing – review & editing

Affiliations Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, North Manchester General Hospital, Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom

Malcolm D. Richardson

Roles Conceptualization, Project administration, Supervision, Writing – review & editing

Affiliations Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, Mycology Reference Centre Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom

David W. Denning

Roles Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing

ddenning@manchester.ac.uk

Affiliations Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, National Aspergillosis Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

Competing Interests

Dr. Denning and family hold Founder shares in F2G Ltd, a University of Manchester spin-out antifungal discovery company. He acts or has recently acted as a consultant to Scynexis, Cidara, Pulmatrix, Zambon, Pulmocide, iCo Therapeutics, Roivant, Biosergen, Mayne Pharma, Bright Angel Therapeutics and Fujifilm. In the last 3 years, he has been paid for talks on behalf of Dynamiker, Hikma, Gilead, Merck, Mylan and Pfizer. He is a longstanding member of the Infectious Disease Society of America Aspergillosis Guidelines group, the European Society for Clinical Microbiology and Infectious Diseases Aspergillosis Guidelines group and the British Society for Medical Mycology Standards of Care committee. Dr. Richardson is the co-founder of Richardson Bio-Tech (Guangzhou) Ltd, acts as a consultant for Gilead Sciences, Pfizer Inc., MSD, Mylan, and gives paid for presentations on behalf of these companies. He is a member of the joint European Confederation for Medical Mycology and European Society for Clinical Mycology and Infectious Diseases Guidelines writing group.